Back
Allegion PLC 10K Form
Sell
28
ALLE
Allegion PLC
Last Price:
$127.18
Seasonality Move:
2.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-25 | 10Q | ALLE/Allegion PLC Quarterly |
2023-10-31 | 10Q | ALLE/Allegion PLC Quarterly |
2023-07-26 | 10Q | ALLE/Allegion PLC Quarterly |
2023-04-26 | 10Q | ALLE/Allegion PLC Quarterly |
2022-10-27 | 10Q | ALLE/Allegion PLC Quarterly |
2022-07-28 | 10Q | ALLE/Allegion PLC Quarterly |
Receive ALLE News And Ratings
See the #1 stock for the next 7 days that we like better than ALLE
ALLE Financial Statistics
Sales & Book Value
Annual Sales: | $3.8B |
---|---|
Cash Flow: | $194.9M |
Price / Cash Flow: | 19.11 |
Annual Sales: | $17.40 |
Price / Book: | 7.31 |
Profitability
EPS (TTM): | 6.82000 |
---|---|
Net Income (TTM): | $597.5M |
Gross Margin: | $1.7B |
Return on Equity: | 41.69% |
Return on Assets: | 13.08% |
Allegion PLC Earnings Forecast
Key Allegion PLC Financial Ratios
-
The Gross Profit Margin over the past 14 years for ALLE is 44.23%.
-
The Selling, General & Administrative Expenses for ALLE have been equal to 23.54% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 17.07% of Operating Income.
-
The Net Earning history of ALLE is 15.84% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 8 years.
Allegion PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Building Products |
Sector: | Industrials |
Current Symbol: | ALLE |
CUSIP: | G0176J |
Website: | allegion.com |
Debt
Debt-to-Equity Ratio: | 1.33 |
---|---|
Current Ratio: | 2.04 |
Quick Ratio: | 1.37 |
Price-to-Earnings
Trailing P/E Ratio: | 18.65 |
---|---|
Forward P/E Ratio: | 15.12 |
ALLE Technical Analysis vs Fundamental Analysis
Sell
28
Allegion PLC (ALLE)
is a Sell
Is Allegion PLC a Buy or a Sell?
-
Allegion PLC stock is rated a SellThe current Allegion PLC [ALLE] share price is $127.16. The Score for ALLE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.